Home > Insider Trading > Filing (0001415889-22-011671)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1583107	Theravance Biopharma Inc.	TBPH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1607965	A. Andrew Hindman	C/O Theravance Biopharma Us, Inc. 901 Gateway Blvd South San Francisco CA 94080	Svp, Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2022-11-18	65,000	$11.02	409,771	No	4	S	Direct
Ordinary Shares	Disposition	2022-11-20	25,057	$10.85	384,714	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	F	Direct

Footnotes

This transaction was executed in multiple trades at prices from $10.7891 to $11.2750. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Includes 1,264 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on November 15, 2022.
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.